Cargando…

Hepatic Dystrophic Calcification Secondary to Transarterial Chemoembolization: Case Report and Review of Literature

Hepatocellular carcinoma (HCC) is a common malignancy usually treated with surgery. Patients who are not suitable for surgery undergo transarterial chemoembolization (TACE) which involves injecting anti-cancer drugs and embolizing agents into the hepatic artery. Although it is a relatively safe proc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Vikash, Shah, Mili, Gala, Dhir, Singh, Manmeet K, Jeanty, Herby, Thomas, Reeny, Forlemu, Arnold N, Gayam, Vijay Reddy, Etienne, Denzil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Family/General Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070055/ https://www.ncbi.nlm.nih.gov/pubmed/37020485 http://dx.doi.org/10.7759/cureus.35765

Ejemplares similares

Pancreatic Heterotopia at the Gastroesophageal Junction: A Case Report and Review of the Literature
por: Kumar, Vikash, et al.
Publicado: (2023)

Outcomes of Portal Vein Thrombosis in Smokers With and Without Cirrhosis and Predictors of Mortality: A Nationwide Assessment
por: Kumar, Vikash, et al.
Publicado: (2023)

An Unusual Case of Drug-Induced Liver Injury Secondary to Nitrofurantoin Use
por: Wonnacott, Stephen, et al.
Publicado: (2022)

Non-islet cell tumor hypoglycemia associated with Gastrointestinal Stromal Tumor: Case report and review of the literature
por: Kumar, Vikash, et al.
Publicado: (2023)

Idiopathic Small Bowel Diaphragm Disease Without Use of Non-steroidal Anti-inflammatory Drugs: A Case Report and Review of the Literature
por: Gala, Dhir, et al.
Publicado: (2022)

Outcomes of Acute Mesenteric Ischemia in End-Stage Renal Disease and Predictors of Mortality: A Nationwide Assessment
por: Kumar, Vikash, et al.
Publicado: (2023)

Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview
por: Gala, Dhir, et al.
Publicado: (2022)

Chicken Bone Ingestion Leads to Aortoesophageal Fistula With Catastrophic Bleeding
por: Nana Sede Mbakop, Raissa, et al.
Publicado: (2023)

“Get Me Off This Medication!”: A Comparison Between Gastroenterology and Primary Care Regarding Patient’s Perceptions of Proton Pump Inhibitor Therapy
por: Khan, Raja Samir, et al.
Publicado: (2020)

Dystrophic myocardial calcification
por: Ananthakrishna, Rajiv, et al.
Publicado: (2016)

Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization
por: Bartnik, Krzysztof, et al.
Publicado: (2021)

Rhabdomyolysis with cardiac dystrophic calcification
por: Das, Biplab, et al.
Publicado: (2016)

Dystrophic calcification in the masseter muscle
por: Walulik, Agata, et al.
Publicado: (2023)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Monckeberg Medial Calcific Sclerosis of the Temporal Artery Masquerading as Giant Cell Arteritis: Case Reports and Literature Review
por: Cuevas Castillo, Francisco J, et al.
Publicado: (2020)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016)

Dystrophic Calcification of the Prostate after Cryotherapy
por: Dru, Christopher, et al.
Publicado: (2014)

Distinguishing dystrophic calcification from calciphylaxis
por: Jones, Elizabeth, et al.
Publicado: (2023)

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma
por: Fukushima, Taito, et al.
Publicado: (2021)

Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
por: Adel, Hatem, et al.
Publicado: (2023)

Frequency of Medication Non-compliance in Hypertensive Patients Presenting with Stroke: A Case-control Study
por: Kumar, Vikash, et al.
Publicado: (2019)

Post-transarterial Chemoembolization Tumor Rupture in a Patient with Autoimmune Hepatitis Cirrhosis and Hepatocellular Carcinoma
por: Gala, Khushboo, et al.
Publicado: (2020)

Rapid aneurysm growth after transarterial chemoembolization
por: Dansey, Kirsten, et al.
Publicado: (2015)

Ultraselective conventional transarterial chemoembolization: When and how?
por: Miyayama, Shiro
Publicado: (2019)

Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Vardar, Baran U, et al.
Publicado: (2022)

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023)

A case of dystrophic calcification in the masseter muscle
por: Kim, Heon-Young, et al.
Publicado: (2017)

Osteosarcoma mimicking fibrous pleurisy with dystrophic calcification!!!
por: Kumar, Tahira Sultana, et al.
Publicado: (2020)

Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study
por: Hu, Hao, et al.
Publicado: (2014)

Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistula
por: Cai, Liang, et al.
Publicado: (2022)

A comparative study of efficacy and safety of transarterial chemoembolization with CalliSpheres and conventional transarterial chemoembolization in treating unresectable intrahepatic cholangiocarcinoma patients
por: Sun, Tao, et al.
Publicado: (2022)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
por: Ren, Yanqiao, et al.
Publicado: (2022)

Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Jun-Ning, et al.
Publicado: (2023)

Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews
por: Yan, Jingxin, et al.
Publicado: (2023)

The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
por: Shin, Sung Wook
Publicado: (2009)

Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014)

Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
por: Nam, Hee Chul, et al.
Publicado: (2016)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
por: Fateen, Waleed, et al.
Publicado: (2017)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
por: Sacco, Rodolfo, et al.
Publicado: (2017)

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient
por: Orlacchio, Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vucg1eeapnhh9f2ontmqdrtmv1